CO6440578A2 - Derivados de 1-alquil-cinolin-4(1h)-ona sustituidos, su preparación y su aplicación en terapéutica - Google Patents

Derivados de 1-alquil-cinolin-4(1h)-ona sustituidos, su preparación y su aplicación en terapéutica

Info

Publication number
CO6440578A2
CO6440578A2 CO11132791A CO11132791A CO6440578A2 CO 6440578 A2 CO6440578 A2 CO 6440578A2 CO 11132791 A CO11132791 A CO 11132791A CO 11132791 A CO11132791 A CO 11132791A CO 6440578 A2 CO6440578 A2 CO 6440578A2
Authority
CO
Colombia
Prior art keywords
alk
group
therapeutics
preparation
application
Prior art date
Application number
CO11132791A
Other languages
English (en)
Inventor
Elodie Barbagallo
Carole Legeay
Murielle Rinaldi-Carmona
Pascale Roux
Claude Vernhet
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41051781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6440578(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of CO6440578A2 publication Critical patent/CO6440578A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/28—Cinnolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención tiene por objeto los compuestos que responden a la fórmula (I) en la que X representa un radical bivalente alquileno(C2-C5) no sustituido o sustituido una o varias veces con un grupo Alk; R1 representa un fenilo, naftilo, piridilo, 1-benzotienilo ó 1,3-benzodioxolilo; R2 representa un átomo de hidrógeno, un átomo de halógeno, un grupo Alk, un grupo OAlk o bien un grupo elegido entre -S-Alk, -SO-Alk, -SO2-AIk, -CO-N(R4)-Alk, -N(R4)SO2-Alk, -N(R4)CO-Alk, -N(R4)SO2-N(Alk)2; R3 representa un átomo de hidrógeno, un átomo de halógeno, un grupo Alk, un grupo OAlk; R4 representa un átomo de hidrógeno o un alquilo(C1-C4); AIk representa un alquilo(C1-C4) no sustituido o sustituido. Procedimiento de preparación y aplicación en terapéutica.
CO11132791A 2009-04-07 2011-10-07 Derivados de 1-alquil-cinolin-4(1h)-ona sustituidos, su preparación y su aplicación en terapéutica CO6440578A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0901696A FR2944013B1 (fr) 2009-04-07 2009-04-07 Derives de 1-alkyl-cinnolin-4(1h)-one substitues,leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
CO6440578A2 true CO6440578A2 (es) 2012-05-15

Family

ID=41051781

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11132791A CO6440578A2 (es) 2009-04-07 2011-10-07 Derivados de 1-alquil-cinolin-4(1h)-ona sustituidos, su preparación y su aplicación en terapéutica

Country Status (20)

Country Link
US (1) US8420651B2 (es)
EP (1) EP2417111B1 (es)
JP (1) JP5651683B2 (es)
KR (1) KR20120027212A (es)
CN (1) CN102459195A (es)
AR (1) AR076205A1 (es)
AU (1) AU2010233590A1 (es)
BR (1) BRPI1015951A2 (es)
CA (1) CA2757859A1 (es)
CL (1) CL2011002500A1 (es)
CO (1) CO6440578A2 (es)
EA (1) EA201171212A1 (es)
FR (1) FR2944013B1 (es)
IL (1) IL215512A0 (es)
MA (1) MA33250B1 (es)
MX (1) MX2011010650A (es)
SG (1) SG175128A1 (es)
TW (1) TW201040147A (es)
UY (1) UY32548A (es)
WO (1) WO2010116084A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY39214A (es) * 2020-05-19 2021-12-31 Syngenta Crop Protection Ag Compuestos herbicidas sustituídos con azufre
BR112022023550A2 (pt) 2020-05-19 2023-01-03 Bayer Cropscience Ag (tio)amidas azabicíclicas como compostos fungicidas
MX2022015625A (es) 2020-06-10 2023-01-11 Bayer Ag Heterociclos sustituidos con azabiciclilo como nuevos fungicidas.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200306839A (en) * 2002-02-06 2003-12-01 Novartis Ag Quinazolinone derivatives and their use as CB agonists
WO2009053799A1 (en) 2007-10-24 2009-04-30 Glenmark Pharmaceuticals, S.A. Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
FR2933697B1 (fr) * 2008-07-11 2010-08-13 Sanofi Aventis Derives de 1-benzyl-cinnolin-4-(1h)-one substitues, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
SG175128A1 (en) 2011-11-28
JP2012522829A (ja) 2012-09-27
AU2010233590A1 (en) 2011-11-03
FR2944013A1 (fr) 2010-10-08
JP5651683B2 (ja) 2015-01-14
WO2010116084A1 (fr) 2010-10-14
IL215512A0 (en) 2011-12-29
EA201171212A1 (ru) 2012-04-30
CL2011002500A1 (es) 2012-03-23
FR2944013B1 (fr) 2011-07-15
EP2417111B1 (fr) 2014-06-04
US8420651B2 (en) 2013-04-16
AR076205A1 (es) 2011-05-26
MX2011010650A (es) 2012-01-20
TW201040147A (en) 2010-11-16
KR20120027212A (ko) 2012-03-21
EP2417111A1 (fr) 2012-02-15
US20120129864A1 (en) 2012-05-24
MA33250B1 (fr) 2012-05-02
UY32548A (es) 2010-11-30
CN102459195A (zh) 2012-05-16
CA2757859A1 (fr) 2010-10-14
BRPI1015951A2 (pt) 2016-04-26

Similar Documents

Publication Publication Date Title
ECSP10010195A (es) Derivados de indolinona y procedimiento para su fabricación
CO6450666A2 (es) Compuesto de piridazinona y su uso
AR079014A1 (es) Composicion de control de plagas
BRPI0608886B8 (pt) derivados de n-sulfonilpirróis e seus usos
ECSP11010912A (es) Compuestos de pirrol
PE20140923A1 (es) Preparacion solida que comprende alogliptina y clorhidrato de metformina
NZ596538A (en) Haloalkyl heteroaryl benzamide compounds
CY1112102T1 (el) Υποκατεστημενες πυριμιδοδιαζεπινες χρησιμες ως αναστολεις plk1
ECSP10010006A (es) Derivado de oxopirazina y herbicida
UY30105A1 (es) Derivados nuevos azufrados de urea cíclica, su preparación y su utilización farmacéutica como inhibidores de quinasas.
DOP2010000272A (es) Nuevos derivados de carbazol inhibidores de hsp90, composiciones que los contienen y utilizacion
AR086590A1 (es) Compuestos de ciclohexanona y herbicidas que los comprenden
AR075701A1 (es) Composicion de control de plagas
NI201100149A (es) Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia.
DOP2011000407A (es) Nuevos derivados de (6-oxo-1,6-dihidro-pirimidin-2-il)-amida, su preparacion y su utilizacion farmaceutica como inhibidores de fosforilacion de akt(pkb)
CO6440578A2 (es) Derivados de 1-alquil-cinolin-4(1h)-ona sustituidos, su preparación y su aplicación en terapéutica
AR093738A1 (es) Formas solidas que comprenden inhibidores de ns5a de hcv, sus composiciones y sus usos
ECSP078009A (es) Derivados del 4,5-diarilpirrol, su preparación y su aplicación en terapéutica
CO6251285A2 (es) Derivado de tetrahidroisoquinolina novedoso
DOP2006000225A (es) Derivados de 6-heteroarilpiridoindolona, su preparación y su aplicación en terapéutica
CO6300943A2 (es) Derivados de 2-oxo-aquil-1-piperazin-2-ona su preparacion y su aplicacion en terapeutica
BR112015028871A2 (pt) novos compostos de 3,4-dihidro-2h-isoquinolina-1-ona e 2,3-dihidro-isoindol-1-ona
BR112013007145A2 (pt) composto ou sal farmacologicamente aceitável, medicamento, e, uso do composto ou sal farmacologicamente aceitável
UY34869A (es) Derivados de pirimidinonas, su preparación y su aplicación en terapéutica.
EA201171011A1 (ru) Производные 6-(6-o-замещенный триазолопиридазинсульфанил)бензотиазолов и -бензимидазолов: получение, применение в качестве лекарственных средств и применение в качестве ингибиторов met

Legal Events

Date Code Title Description
FC Application refused